.jpg "Kathy Warye, BS photo")
Founder and Principal
Infection Prevention Partners
Sonoma, California, United States
Ms. Warye is the founder of Infection Prevention Partners, a consultancy committed to advancing the development and adoption of innovative solutions for the detection, prevention or management of infection. Her clients include medical device, diagnostic and pharmaceutical companies at the forefront of infection prevention and control. In 2010, Ms. Warye was named one of the “100 Most Powerful People in Healthcare” by Modern Healthcare Magazine for her influence in driving awareness of healthcare-associated infections (HAIs) and leadership in mobilizing a diverse community of stakeholders toward their reduction.
In 2011, she was recruited to Becton Dickinson (BD) to advance the company’s clinical and commercial leadership in infection prevention. As Worldwide Vice President of Infection Prevention, she led global infection prevention portfolio development and market shaping strategy. She and her team paved the way for the company’s acquisition of CareFusion, a leader in infection prevention solutions.
Prior to joining BD, Ms. Warye held the position of CEO for the Association for Professionals in Infection Control and Epidemiology (APIC) where she focused national attention to the problem of HAIs. From 2003-2010, she worked closely with the healthcare delivery, corporate and government communities to advance the business case for infection prevention and to develop both clinical and public policy solutions to reduce HAIs. She is recognized for transforming APIC from an under-the-radar professional society into a vibrant, globally recognized leader in patient safety, healthcare policy, clinical practice and research. APIC is the largest infection prevention organization in the world with 120 chapters in North America, Asia, Africa and the Middle East.
Ms. Warye is a seasoned public speaker having made presentations to both industry and association audiences in over 20 countries.
Avidicare AB (Consultant/Advisory Board)
Saturday, March 19, 2022
9:30 AM – 10:30 AM CDT
Friday, March 25, 2022